|
US2020316108A1
|
|
Methods and Compositions for Treating Chlorine-Gas Induced Lung Injury
|
|
US2020113508A1
|
|
Methods of Identifying Atopic Dermatitis and Food Allergies
|
|
US2019224203A1
|
|
Methods of treating steroid resistant diseases and conditions
|
|
WO2019046433A1
|
|
Methods and compositions for treating infection and inflammation with selenocyanate
|
|
WO2019006354A1
|
|
Methods of detecting and reducing cancer cell central nervous system colonization
|
|
WO2018157107A1
|
|
Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs
|
|
US2018224470A1
|
|
Lipid Abnormalities and Association with Atopic Allergic Diseases
|
|
US2017330320A1
|
|
Systems and methods for automatic detection and quantification of pathology using dynamic feature classification
|
|
WO2017147492A1
|
|
Methods of detecting and treating airway inflammatory diseases
|
|
US2017176455A1
|
|
Methods of detecting and preventing atopic allergic diseases
|
|
US2017087166A1
|
|
Methods for treating and preventing allergies and acute allergic responses
|
|
US2017102395A1
|
|
Methods for diagnosing and treating subjects for pulmonary exacerbation
|
|
US2016361414A1
|
|
Methods of Treating and Preventing Minor Histocompatibility Antigen-Mismatched Grafts
|
|
US2016312285A1
|
|
Methods of identifying and treating subjects having acute respiratory distress syndrome
|
|
WO2016168343A1
|
|
Thiocyanate salts for anti-inflammation
|
|
US2016282363A1
|
|
Methods of Treating Subjects having Severe and/or Persistent Asthma
|
|
US2016215344A1
|
|
Methods of Identifying and Treating Subjects having Inflammatory Subphenotypes of Asthma
|
|
WO2016073764A1
|
|
Device and method to facilitate pleurodesis for management of fluid drainage
|
|
US2015322520A1
|
|
Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
|
|
US2017003300A1
|
|
Methods for detection of respiratory diseases
|
